AKBA icon

Akebia Therapeutics

90 hedge funds and large institutions have $16.5M invested in Akebia Therapeutics in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 32 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

18% less capital invested

Capital invested by funds: $20.2M → $16.5M (-$3.69M)

25% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 16

47% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 32

Holders
90
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$292K
Puts
$47K
Net Calls
Net Calls Change

Top Buyers

1 +$485K
2 +$400K
3 +$154K
4
Two Sigma Investments
Two Sigma Investments
New York
+$102K
5
Marshall Wace
Marshall Wace
United Kingdom
+$101K

Top Sellers

1 -$973K
2 -$593K
3 -$322K
4
AQR Capital Management
AQR Capital Management
Connecticut
-$304K
5
E
Ergoteles
New York
-$215K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$4.17M
2
$2.37M
3
$1.47M
4
$1.36M
5
$1.1M
6
$954K
7
$646K
8
$569K
9
$512K
10
$199K
11
$195K
12
$181K
13
$170K
14
$161K
15
$154K
16
$147K
17
$146K
18
$131K
19
$127K
20
$114K
21
$110K
22
$101K
23
$95K
24
$90K
25
$80K